TORONTO — Novo Nordisk Canada is considering competing with generic versions of its brand-name Ozempic and Wegovy drugs by introducing renamed, lower-priced copies of the medications. TORONTO — Novo ...
Add Yahoo as a preferred source to see more of our stories on Google. Ozempic, pictured in May 2022, contains semaglutide, which is used to treat diabetes and obesity. Health Canada says it is ...
Drug companies in Canada are allowed to make lower priced generic versions of the blockbuster drug Ozempic as of next week, but experts say patients shouldn’t expect it to be available for at least a ...
Canadian employers and their employees can expect to see drug plan savings as generic versions of diabetes and obesity medications are introduced, cutting insurance costs. Ozempic and Wegovy – two ...
Novo Nordisk AS is lowering prices of its top-selling WeGovy weight-loss drug in China, as the Danish drugmaker braces for intense competition from local rivals next year when the patent for its ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
Cuban urges FDA fee waiver to boost US generics manufacturing Cost Plus Drugs plans to boost US production if fees are waived FDA charges $360,000 per generic drug approval application Trump promised ...
Former SurveyMonkey and Salesforce executives bring proven experience leading high-performance teams and scaling category-defining products across global markets. Iterable’s leadership evolution comes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback